{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:26:08Z","timestamp":1790241968877,"version":"4.1.0"},"reference-count":71,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2014,8,28]],"date-time":"2014-08-28T00:00:00Z","timestamp":1409184000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0003025","type":"journal-article","created":{"date-parts":[[2014,8,28]],"date-time":"2014-08-28T17:58:15Z","timestamp":1409248695000},"page":"e3025","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":65,"title":["Dengue Therapeutics, Chemoprophylaxis, and Allied Tools: State of the Art and Future Directions"],"prefix":"10.1371","volume":"8","author":[{"given":"James","family":"Whitehorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Yacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Anders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis R.","family":"Macareo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Cristina","family":"Cassetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinh Chau","family":"Nguyen Van","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Yong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Wills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron P.","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,8,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1056\/NEJMra1110265","article-title":"Dengue","volume":"366","author":"CP Simmons","year":"2012","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"S Bhatt","year":"2013","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"S830","DOI":"10.1093\/clinids\/11.Supplement_4.S830","article-title":"Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade","volume":"11 Suppl 4","author":"SB Halstead","year":"1989","journal-title":"Rev Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1099\/0022-1317-75-9-2387","article-title":"The differentiation state of monocytic cells affects their susceptibility to infection and the effects of infection by dengue virus","volume":"75","author":"MA O'Sullivan","year":"1994","journal-title":"J Gen Virol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"9072","DOI":"10.1073\/pnas.1303395110","article-title":"Host and viral features of human dengue cases shape the population of infected and infectious Aedes aegypti mosquitoes","volume":"110","author":"MN Nguyet","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/cid\/cit594","article-title":"Clinical characteristics of dengue shock syndrome in Vietnamese children: a 10-year prospective study in a single hospital","volume":"57","author":"P Lam","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"7221","DOI":"10.1016\/j.vaccine.2011.07.022","article-title":"The pathogenesis of dengue","volume":"29","author":"J Whitehorn","year":"2011","journal-title":"Vaccine"},{"key":"ref8","unstructured":"WHO (2009) Dengue: guidelines for diagnosis, treatment, prevention and control - New edition. Geneva: World Health Organisation."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.4269\/ajtmh.2007.77.1135","article-title":"Lack of efficacy of high-dose intravenous immunoglobulin treatment of severe thrombocytopenia in patients with secondary dengue virus infection","volume":"77","author":"EM Dimaano","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.homp.2006.10.004","article-title":"The use of homeopathic combination remedy for dengue fever symptoms: a pilot RCT in Honduras","volume":"96","author":"J Jacobs","year":"2007","journal-title":"Homeopathy"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/pgmj.2008.078444","article-title":"Efficacy of low dose dexamethasone in severe thrombocytopenia caused by dengue fever: a placebo controlled study","volume":"85","author":"SA Kularatne","year":"2009","journal-title":"Postgrad Med J"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"737","DOI":"10.4269\/ajtmh.2007.76.737","article-title":"Thrombocytopenia associated with dengue hemorrhagic fever responds to intravenous administration of anti-D (Rh(0)-D) immune globulin","volume":"76","author":"RA de Castro","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"370872","DOI":"10.1155\/2011\/370872","article-title":"Modulation of cytokine and cytokine receptor\/antagonist by treatment with doxycycline and tetracycline in patients with dengue Fever","volume":"2011","author":"JE Castro","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/INF.0b013e3182575e6a","article-title":"Use of pentoxifylline in treatment of children with dengue hemorrhagic fever","volume":"31","author":"D Salgado","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"ref15","first-page":"38","article-title":"Oral calcium administration attenuates thrombocytopenia in patients with dengue fever. Report of a pilot study","volume":"51","author":"JI Cabrera-Cortina","year":"2008","journal-title":"Proc West Pharmacol Soc"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e785","DOI":"10.1371\/journal.pntd.0000785","article-title":"A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults","volume":"4","author":"V Tricou","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/infdis\/jis470","article-title":"A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients","volume":"207","author":"NM Nguyen","year":"2013","journal-title":"J Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/cid\/cis655","article-title":"Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial","volume":"55","author":"DT Tam","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1745-6215-13-203","article-title":"Lovastatin for adult patients with dengue: protocol for a randomised controlled trial","volume":"13","author":"J Whitehorn","year":"2012","journal-title":"Trials"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S1473-3099(14)70730-3","article-title":"Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial","volume":"14","author":"J Low","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e2592","DOI":"10.1371\/journal.pntd.0002592","article-title":"Corticosteroids for dengue - why don't they work?","volume":"7","author":"TH Nguyen","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1128\/JVI.02841-13","article-title":"Activation of PBMCs by dengue virus infection depotentiates Balapiravir","volume":"88","author":"YL Chen","year":"2013","journal-title":"J Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.antiviral.2012.07.008","article-title":"Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial","volume":"96","author":"S Watanabe","year":"2012","journal-title":"Antiviral Res"},{"key":"ref24","first-page":"860","article-title":"Celgosivir, an alpha-glucosidase I inhibitor for the potential treatment of HCV infection","volume":"10","author":"D Durantel","year":"2009","journal-title":"Curr Opin Investig Drugs"},{"key":"ref25","first-page":"CD004816","article-title":"Statins for the primary prevention of cardiovascular disease","volume":"1","author":"F Taylor","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/jac\/dkn019","article-title":"Statins for infection and sepsis: a systematic review of the clinical evidence","volume":"61","author":"ME Falagas","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1007\/s00134-006-0246-y","article-title":"Association of statin therapy and increased survival in patients with multiple organ dysfunction syndrome","volume":"32","author":"H Schmidt","year":"2006","journal-title":"Intensive Care Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s11606-011-1826-2","article-title":"Association between statins given in hospital and mortality in pneumonia patients","volume":"27","author":"MB Rothberg","year":"2012","journal-title":"J Gen Intern Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa044057","article-title":"Comparison of three fluid solutions for resuscitation in dengue shock syndrome","volume":"353","author":"BA Wills","year":"2005","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1086\/520435","article-title":"Fluid replacement in dengue shock syndrome: a randomized, double-blind comparison of four intravenous-fluid regimens","volume":"29","author":"NM Dung","year":"1999","journal-title":"Clin Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1086\/318479","article-title":"Acute management of dengue shock syndrome: a randomized double-blind comparison of 4 intravenous fluid regimens in the first hour","volume":"32","author":"NT Ngo","year":"2001","journal-title":"Clin Infect Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"R280","DOI":"10.1186\/cc13135","article-title":"Development of clinical decision rules to predict recurrent shock in dengue","volume":"17","author":"NT Huy","year":"2013","journal-title":"Crit Care"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1056\/NEJMoa1204242","article-title":"Hydroxyethyl starch 130\/0.42 versus Ringer's acetate in severe sepsis","volume":"367","author":"A Perner","year":"2012","journal-title":"N Engl J Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/cc13027","article-title":"Should hydroxyethyl starch solutions be totally banned?","volume":"17","author":"JL Vincent","year":"2013","journal-title":"Crit Care"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3201\/eid1701.100321","article-title":"Change in age pattern of persons with dengue, northeastern Brazil","volume":"17","author":"LP Cavalcanti","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3201\/eid1206.051210","article-title":"Dengue prevention and 35 years of vector control in Singapore","volume":"12","author":"EE Ooi","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e1716","DOI":"10.1371\/journal.pntd.0001716","article-title":"Prophylactic platelets in dengue: survey responses highlight lack of an evidence base","volume":"6","author":"J Whitehorn","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1086\/597773","article-title":"Lack of efficacy of prophylactic platelet transfusion for severe thrombocytopenia in adults with acute uncomplicated dengue infection","volume":"48","author":"DC Lye","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/j.1537-2995.2009.02132.x","article-title":"Prospective observational study of low thresholds for platelet transfusion in adult dengue patients","volume":"49","author":"L Thomas","year":"2009","journal-title":"Transfusion"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1067\/mpd.2002.123665","article-title":"Risk factors for hemorrhage in severe dengue infections","volume":"140","author":"LC Lum","year":"2002","journal-title":"J Pediatr"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1067\/S0022-3476(03)00503-1","article-title":"Preventive transfusion in Dengue shock syndrome-is it necessary?","volume":"143","author":"LC Lum","year":"2003","journal-title":"J Pediatr"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000354837","article-title":"Effectiveness of platelet transfusion in dengue Fever: a randomized controlled trial","volume":"40","author":"MZ Khan Assir","year":"2013","journal-title":"Transfus Med Hemother"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.antiviral.2013.09.013","article-title":"Ten years of dengue drug discovery: progress and prospects","volume":"100","author":"SP Lim","year":"2013","journal-title":"Antiviral Res"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"20435","DOI":"10.1073\/pnas.0907010106","article-title":"An adenosine nucleoside inhibitor of dengue virus","volume":"106","author":"Z Yin","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"11183","DOI":"10.1128\/JVI.05468-11","article-title":"Inhibition of dengue virus by targeting viral NS4B protein","volume":"85","author":"X Xie","year":"2011","journal-title":"J Virol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.antiviral.2013.01.004","article-title":"An iminosugar with potent inhibition of dengue virus infection in vivo","volume":"98","author":"ST Perry","year":"2013","journal-title":"Antiviral Res"},{"key":"ref47","first-page":"139ra183","article-title":"The structural basis for serotype-specific neutralization of dengue virus by a human antibody","volume":"4","author":"EP Teoh","year":"2012","journal-title":"Sci Transl Med"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.antiviral.2006.06.006","article-title":"Selective inhibitors of hepatitis C virus replication","volume":"71","author":"J Neyts","year":"2006","journal-title":"Antiviral Res"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.antiviral.2012.06.008","article-title":"Nuclear trafficking of proteins from RNA viruses: potential target for antivirals?","volume":"95","author":"L Caly","year":"2012","journal-title":"Antiviral Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1042\/BJ20120150","article-title":"Ivermectin is a specific inhibitor of importin alpha\/beta-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus","volume":"443","author":"KM Wagstaff","year":"2012","journal-title":"Biochem J"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/jac\/dks147","article-title":"Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug","volume":"67","author":"E Mastrangelo","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/978-1-62703-484-5_21","article-title":"Testing antiviral compounds in a dengue mouse model","volume":"1030","author":"W Schul","year":"2013","journal-title":"Methods Mol Biol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/v4010062","article-title":"Animal models of dengue virus infection","volume":"4","author":"S Zompi","year":"2012","journal-title":"Viruses"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"e657","DOI":"10.1371\/journal.pntd.0000657","article-title":"Clinical and virological features of Dengue in Vietnamese infants","volume":"4","author":"TN Chau","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/infdis\/128.1.7","article-title":"Studies on the pathogenesis of dengue infection in monkeys. I. Clinical laboratory responses to primary infection","volume":"128","author":"SB Halstead","year":"1973","journal-title":"J Infect Dis"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1128\/AAC.49.11.4508-4514.2005","article-title":"Randomized, placebo-controlled trial of nonpegylated and pegylated forms of recombinant human alpha interferon 2a for suppression of dengue virus viremia in rhesus monkeys","volume":"49","author":"C Ajariyakhajorn","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1182\/blood-2009-09-242990","article-title":"Dengue virus-induced hemorrhage in a nonhuman primate model","volume":"115","author":"N Onlamoon","year":"2010","journal-title":"Blood"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1099\/vir.0.031229-0","article-title":"Common marmoset (Callithrix jacchus) as a primate model of dengue virus infection: development of high levels of viraemia and demonstration of protective immunity","volume":"92","author":"T Omatsu","year":"2011","journal-title":"J Gen Virol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.4161\/hv.24188","article-title":"Dengue human infection model: re-establishing a tool for understanding dengue immunology and advancing vaccine development","volume":"9","author":"SJ Thomas","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/infdis\/jis744","article-title":"Experimental dengue virus challenge of human subjects previously vaccinated with live attenuated tetravalent dengue vaccines","volume":"207","author":"W Sun","year":"2013","journal-title":"J Infect Dis"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/CIRCULATIONAHA.106.652859","article-title":"Endothelial function and dysfunction: testing and clinical relevance","volume":"115","author":"JE Deanfield","year":"2007","journal-title":"Circulation"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1086\/590209","article-title":"Recovery of endothelial function in severe falciparum malaria: relationship with improvement in plasma L-arginine and blood lactate concentrations","volume":"198","author":"TW Yeo","year":"2008","journal-title":"J Infect Dis"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"R155","DOI":"10.1186\/cc8055","article-title":"Sepsis-associated microvascular dysfunction measured by peripheral arterial tonometry: an observational study","volume":"13","author":"JS Davis","year":"2009","journal-title":"Crit Care"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s00134-010-2005-3","article-title":"Monitoring the microcirculation in the critically ill patient: current methods and future approaches","volume":"36","author":"D De Backer","year":"2010","journal-title":"Intensive Care Med"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1164\/rccm.200109-016OC","article-title":"Microvascular blood flow is altered in patients with sepsis","volume":"166","author":"D De Backer","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00134-010-1843-3","article-title":"Effects of fluids on microvascular perfusion in patients with severe sepsis","volume":"36","author":"G Ospina-Tascon","year":"2010","journal-title":"Intensive Care Med"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/CCM.0b013e3181986647","article-title":"Effects of hydrocortisone on microcirculatory alterations in patients with septic shock","volume":"37","author":"GL Buchele","year":"2009","journal-title":"Crit Care Med"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1084\/jem.20070819","article-title":"Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria","volume":"204","author":"TW Yeo","year":"2007","journal-title":"J Exp Med"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1549-8719.2011.00142.x","article-title":"Spotlight issue: Microcirculation-from a clinical perspective","volume":"19","author":"G Clough","year":"2012","journal-title":"Microcirculation"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0140-6736(12)61428-7","article-title":"Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial","volume":"380","author":"A Sabchareon","year":"2012","journal-title":"Lancet"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"e1752","DOI":"10.1371\/journal.pntd.0001752","article-title":"Therapeutics for dengue: recommendations for design and conduct of early-phase clinical trials","volume":"6","author":"CP Simmons","year":"2012","journal-title":"PLoS Negl Trop Dis"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0003025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T08:22:42Z","timestamp":1689495762000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0003025"}},"subtitle":[],"editor":[{"given":"Alan L.","family":"Rothman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,8,28]]},"references-count":71,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,8,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0003025","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,28]]}}}